Published on in Vol 10 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/44216, first published
.

Journals
- Nardo E, Parchuri E, O’Brien J, Crosby L, Porter J, Palermo T, Nikolajski C, Treadwell M, Hillery C, Szigethy E, Jonassaint C. The effect of an adapted digital mental health intervention for sickle cell disease on engagement: a pilot randomized controlled trial. BMC Digital Health 2023;1(1) View
- Tamboli M, MacArthur E, Collins N, Kang E, Fernandez M, Porter J, Conklin H, King A, Hankins J, Heitzer A. Caregiver and provider perspectives on developmental services for children with sickle cell disease: a mixed methods analysis. Frontiers in Pediatrics 2025;13 View
- Abrams C, Davila N, Badawy S, Kepper M, Gibson R, King A, Gordeuk V, Nwosu C, Li S, Glassberg J, Klesges L, Shah N, Brambilla D, Hankins J. User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease. Pediatric Blood & Cancer 2025;72(7) View
- Oluwole O, McGill L, Gayle K, O'Brien J, Abebe K, Jonassaint C, Hamm M. Experiences With a Multicomponent Digital Behavioral Pain Management Intervention for Adults With Sickle Cell Disease: Qualitative Analysis of the CaRISMA Trial. JMIR Human Factors 2025;12:e73719 View
- Ovalles A, Parsons E, Steinberg M, Ball T, Edwards R, Checko E, Carl J, Smits J, Otto M. Preference for the modality of psychosocial treatment for anxiety in adults with comorbid anxiety and chronic musculoskeletal pain. Cognitive Behaviour Therapy 2025:1 View
- Michael F, Nwozichi C, Salako O, Oshodi‐Bakare M, Olaogun E, Nang‐Bayi J. Exploring the Lived Experiences of Adults With Sickle Cell Disease in Nigeria Using van Manen's Phenomenological Approach. Public Health Challenges 2025;4(4) View
